Number of Infections and Incidence* per 100,000 Persons
*Annual incidence is reported as cases per 100,000 persons. Incidence is calculated by dividing the total number of infections with each pathogen by the population in the FoodNet surveillance system for that year.
Pathogen/Syndrome | Year | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | |
Surveillance population (millions)†† | 44.34 | 44.77 | 45.32 | 45.84 | 46.33 | 46.76 | 47.15 | 47.53 | 47.92 | 48.27 | 48.64 | 48.64 |
Campylobacter | 5,686 | 5,692 | 5,770 | 5,871 | 5,859 | 6,066 | 6,375 | 6,785 | 6,810 | 6,622 | 6,465 | 6,309 |
Listeria† | 114 | 131 | 129 | 118 | 121 | 149 | 125 | 135 | 123 | 123 | 116 | 116 |
Salmonella | 6,498 | 6,504 | 6,689 | 6,828 | 7,459 | 7,029 | 8,274 | 7,815 | 7,843 | 7,307 | 7,439 | 7,728 |
Shigella | 2,248 | 2,095 | 2,765 | 2,869 | 3,043 | 1,854 | 1,779 | 1,541 | 2,141 | 2,333 | 2,774 | 2,688 |
STEC§ O157 | 402 | 473 | 590 | 548 | 518 | 461 | 446 | 463 | 533 | 553 | 444 | 463 |
STEC non-O157 | 113 | 134 | 238 | 283 | 247 | 286 | 451 | 522 | 557 | 571 | 697 | 796 |
Vibrio | 123 | 121 | 156 | 110 | 136 | 161 | 195 | 157 | 198 | 249 | 221 | 192 |
Yersinia | 175 | 163 | 163 | 164 | 166 | 152 | 159 | 163 | 159 | 173 | 136 | 139 |
Cryptosporidium | 637 | 1,327 | 879 | 1,225 | 1,052 | 1,348 | 1,296 | 1,358 | 1,258 | 1,217 | 1,189 | 1,612 |
Cyclospora | 15 | 65 | 43 | 13 | 17 | 32 | 28 | 22 | 15 | 14 | 26 | 64 |
HUS** | 31 | 44 | 66 | 62 | 52 | 44 | 57 | 38 | 44 | 46 | 30 | – |
*Data are preliminary
†Listeria cases defined as isolation of L. monocytogenes from a normally sterile site or, in the setting of miscarriage or stillbirth, isolation of L. monocytogenes from placental or fetal tissue
§Shiga toxin-producing Escherichia coli
¶Surveillance not conducted for this pathogen in this year
**Numbers of cases of postdiarrheal HUS in children aged <5 years
††U.S. Census Bureau population estimates for the surveillance area for 2014. Final incidence rates will be reported when population estimates for 2015 are available.
Download the table (pre-2004 data included): Table 2a. Number and Incidence of Infections by Year, 1996-2015 Cdc-excel
Pathogen / Syndrome |
Year | 2010 National health objective§ |
2020 National health objective¶ |
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | |||
Surveillance population (millions)††† |
44.34 | 44.77 | 45.32 | 45.84 | 46.33 | 46.76 | 47.15 | 47.53 | 47.92 | 48.27 | 48.64 | 48.64 | ||
Campylobacter | 12.82 | 12.71 | 12.73 | 12.81 | 12.65 | 12.97 | 13.52 | 14.27 | 14.21 | 13.72 | 13.29 | 12.97 | 12.3 | 8.5 |
Listeria** | 0.26 | 0.29 | 0.28 | 0.26 | 0.26 | 0.32 | 0.27 | 0.28 | 0.26 | 0.25 | 0.24 | 0.24 | 0.24 | 0.2 |
Salmonella | 14.65 | 14.53 | 14.76 | 14.89 | 16.10 | 15.03 | 17.55 | 16.44 | 16.37 | 15.14 | 15.29 | 15.89 | 6.8 | 11.4 |
Shigella | 5.07 | 4.68 | 6.10 | 6.26 | 6.57 | 3.96 | 3.77 | 3.24 | 4.47 | 4.83 | 5.7 | 5.53 | N/A ++ | N/A |
STEC§§ O157 | 0.91 | 1.06 | 1.30 | 1.20 | 1.12 | 0.99 | 0.95 | 0.97 | 1.11 | 1.15 | 0.91 | 0.95 | 1.0 | 0.6 |
STEC non-O157 | 0.25 | 0.30 | 0.53 | 0.62 | 0.53 | 0.61 | 0.96 | 1.10 | 1.16 | 1.19 | 1.43 | 1.64 | N/A | N/A |
Vibrio | 0.28 | 0.27 | 0.34 | 0.24 | 0.29 | 0.34 | 0.41 | 0.33 | 0.41 | 0.52 | 0.45 | 0.39 | N/A | 0.2 |
Yersinia | 0.39 | 0.36 | 0.36 | 0.36 | 0.36 | 0.33 | 0.34 | 0.34 | 0.33 | 0.36 | 0.28 | 0.29 | N/A | 0.3 |
Cryptosporidium | 1.44 | 2.96 | 1.94 | 2.67 | 2.27 | 2.88 | 2.75 | 2.86 | 2.63 | 2.52 | 2.44 | 3.31 | N/A | N/A |
Cyclospora | 0.03 | 0.15 | 0.09 | 0.03 | 0.04 | 0.07 | 0.06 | 0.05 | 0.03 | 0.03 | 0.05 | 0.13 | N/A | N/A |
HUS*** | 1.05 | 1.48 | 2.21 | 2.05 | 1.71 | 1.45 | 1.88 | 1.26 | 1.47 | 1.55 | 1.01 | – | N/A | 0.9 |
*Per 100,000 population
†Data are preliminary
§Healthy People 2010 objective targets for incidence of Campylobacter, Listeria, Salmonella, and Shiga toxin-producing Escherichia coli O157 infections
¶Healthy People 2020 objective targets for incidence of Campylobacter, Listeria, Salmonella, Shiga toxin-producing Escherichia coli O157, Vibrio, and Yersinia infections, and HUS
**Listeria cases defined as isolation of L. monocytogenes from a normally sterile site or, in the setting of miscarriage or stillbirth, isolation of L. monocytogenes from placental or fetal tissue
††No national health objective exists for these pathogens
§§Shiga toxin-producing Escherichia coli
¶¶Surveillance not conducted for this pathogen in this year
***Incidence of postdiarrheal HUS in children aged <5 years; denominator is surveillance population aged <5 years
†††U.S. Census Bureau population estimates for the surveillance area for 2014. Final incidence rates will be reported when population estimates for 2015 are available.
Download the table (pre-2004 data included): Table 2b. Number and Incidence of Infections by Year, 1996-2015 Cdc-excel
Pathogen/Syndrome | California† | Colorado† | Connecticut | Georgia | Maryland | Minnesota | New Mexico | New York† | Oregon | Tennessee | Total 2015 |
---|---|---|---|---|---|---|---|---|---|---|---|
Campylobacter | 624 | 397 | 700 | 739 | 690 | 922 | 356 | 632 | 849 | 400 | 6,309 |
Listeria§ | 19 | 5 | 22 | 16 | 12 | 3 | 3 | 15 | 14 | 7 | 116 |
Salmonella | 598 | 316 | 450 | 2,157 | 931 | 976 | 423 | 486 | 518 | 873 | 7,728 |
Shigella | 291 | 66 | 59 | 1,370 | 197 | 292 | 70 | 43 | 106 | 194 | 2,688 |
STEC¶ O157 | 47 | 38 | 27 | 28 | 22 | 115 | 7 | 27 | 108 | 44 | 463 |
STEC non-O157 | 116 | 72 | 56 | 76 | 50 | 124 | 26 | 58 | 109 | 109 | 796 |
Vibrio | 36 | 5 | 30 | 23 | 37 | 20 | 1 | 10 | 25 | 5 | 192 |
Yersinia | 15 | 6 | 9 | 19 | 18 | 23 | 2 | 18 | 21 | 8 | 139 |
Cryptosporidium | 63 | 69 | 77 | 391 | 103 | 316 | 54 | 99 | 197 | 243 | 1,612 |
Cyclospora | 3 | 3 | 16 | 34 | 3 | 1 | 2 | 2 | 0 | 0 | 64 |
Total | 1,812 | 977 | 1,446 | 4,853 | 2,063 | 2,792 | 944 | 1,390 | 1,947 | 1,883 | 20,107 |
HUS** | 2 | 1 | 1 | 3 | 3 | 5 | 1 | 0 | 4 | 10 | 30 |
*Data are preliminary
†This FoodNet site includes only selected counties. California: Alameda, Contra Costa, and San Francisco; Colorado: Adams, Arapahoe, Boulder, Broomfield, Denver, Douglas, and Jefferson; New York: Albany, Allegany, Cattaraugus, Chautauqua, Chemung, Clinton, Columbia, Delaware, Erie, Essex, Franklin, Fulton, Genesee, Greene, Hamilton, Livingston, Monroe, Montgomery, Niagara, Ontario, Orleans, Otsego, Rensselaer, Saratoga, Schenectady, Schoharie, Schuyler, Seneca, Steuben, Warren, Washington, Wayne, Wyoming, and Yates.
§Listeria cases defined as isolation of L. monocytogenes from a normally sterile site or, in the setting of miscarriage or stillbirth, isolation of L. monocytogenes from placental or fetal tissue
¶Shiga toxin-producing Escherichia coli
**Numbers of cases of postdiarrheal HUS in children aged <5 years
Download the table: Table 3a. Number and Incidence of Infections by Site, 2015 Cdc-excel
Pathogen / Syndrome | California§ | Colorado§ | Connecticut | Georgia | Maryland | Minnesota | New Mexico | New York§ | Oregon | Tennessee | Total 2015 | 2010 National health objective¶ | 2020 National health objective** |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Surveillance population (millions)††† | 3.57 | 3.01 | 3.60 | 10.10 | 5.98 | 5.46 | 2.09 | 4.32 | 3.97 | 6.50 | 48.64 | ||
Campylobacter | 17.46 | 13.18 | 19.46 | 7.32 | 11.55 | 16.90 | 17.07 | 14.62 | 21.38 | 6.11 | 12.97 | 12.3 | 8.5 |
Listeria†† | 0.53 | 0.17 | 0.61 | 0.16 | 0.20 | 0.05 | 0.14 | 0.35 | 0.35 | 0.11 | 0.24 | 0.24 | 0.2 |
Salmonella | 16.73 | 10.49 | 12.51 | 21.36 | 15.58 | 17.88 | 20.28 | 11.24 | 13.05 | 13.33 | 15.89 | 6.8 | 11.4 |
Shigella | 8.14 | 2.19 | 1.64 | 13.57 | 3.30 | 5.35 | 3.36 | 0.99 | 2.67 | 2.96 | 5.53 | N/A§§ | N/A |
STEC¶¶ O157 | 1.31 | 1.26 | 0.75 | 0.28 | 0.37 | 2.11 | 0.34 | 0.62 | 2.72 | 0.67 | 0.95 | 1.0 | 0.6 |
STEC non-O157 | 3.25 | 2.39 | 1.56 | 0.75 | 0.84 | 2.27 | 1.25 | 1.34 | 2.75 | 1.66 | 1.67 | N/A | N/A |
Vibrio | 1.01 | 0.17 | 0.83 | 0.23 | 0.62 | 0.37 | 0.05 | 0.23 | 0.63 | 0.08 | 0.39 | N/A | 0.2 |
Yersinia | 0.42 | 0.20 | 0.25 | 0.19 | 0.30 | 0.42 | 0.10 | 0.42 | 0.53 | 0.12 | 0.29 | N/A | 0.3 |
Cryptosporidium | 1.76 | 2.29 | 2.14 | 3.87 | 1.72 | 5.79 | 2.59 | 2.29 | 4.96 | 3.71 | 3.31 | N/A | N/A |
Cyclospora | 0.08 | 0.10 | 0.44 | 0.34 | 0.05 | 0.02 | 0.10 | 0.05 | 0.00 | 0.00 | 0.13 | N/A | N/A |
HUS*** | 0.99 | 0.52 | 0.53 | 0.45 | 0.81 | 1.43 | 0.73 | 0.00 | 1.74 | 2.50 | 1.01 | N/A | 0.9 |
*Per 100,000 population
†Data are preliminary
§This FoodNet site includes only selected counties. California: Alameda, Contra Costa, and San Francisco; Colorado: Adams, Arapahoe, Boulder, Broomfield, Denver, Douglas, and Jefferson; New York: Albany, Allegany, Cattaraugus, Chautauqua, Chemung, Clinton, Columbia, Delaware, Erie, Essex, Franklin, Fulton, Genesee, Greene, Hamilton, Livingston, Monroe, Montgomery, Niagara, Ontario, Orleans, Otsego, Rensselaer, Saratoga, Schenectady, Schoharie, Schuyler, Seneca, Steuben, Warren, Washington, Wayne, Wyoming, and Yates.
¶Healthy People 2010 objective targets for incidence of Campylobacter, Listeria, Salmonella, and Shiga toxin-producing Escherichia coli O157 infections
**Healthy People 2020 objective targets for incidence of Campylobacter, Listeria, Salmonella, Shiga toxin-producing Escherichia coli O157, Vibrio, and Yersinia infections, and HUS
††Listeria cases defined as isolation of L. monocytogenes from a normally sterile site or, in the setting of miscarriage or stillbirth, isolation of L. monocytogenes from placental or fetal tissue
§§No national health objective exists for these pathogens
¶¶Shiga toxin-producing Escherichia coli
***Incidence of postdiarrheal HUS in children aged <5 years; denominator is surveillance population aged <5 years
†††U.S. Census Bureau population estimates for the surveillance area for 2014. Final incidence rates will be reported when population estimates for 2015 are available.
Download the table: Table 3b. Number and Incidence of Infections by Site, 2015 Cdc-excel
Pathogen | Age group (yrs) | |||||
---|---|---|---|---|---|---|
<5 | 5-9 | 10-19 | 20-64 | ≥65 | Total | |
Total | 3,485 | 1,656 | 1,854 | 10,484 | 2,624 | 20,107 |
Campylobacter | 633 | 254 | 507 | 3,918 | 996 | 6,309 |
Listeria† | 9 | 0 | 0 | 41 | 66 | 116 |
Salmonella | 1,702 | 553 | 683 | 3,693 | 1,096 | 7,728 |
Shigella | 582 | 560 | 211 | 1,231 | 104 | 2,688 |
STEC§ O157 | 110 | 74 | 89 | 156 | 34 | 463 |
STEC non-O157 | 200 | 62 | 148 | 313 | 73 | 796 |
Vibrio | 2 | 12 | 10 | 123 | 45 | 192 |
Yersinia | 22 | 5 | 13 | 60 | 39 | 139 |
Cryptosporidium | 225 | 136 | 192 | 898 | 159 | 1,612 |
Cyclospora | 0 | 0 | 1 | 51 | 12 | 64 |
*Data are preliminary
†Listeria cases defined as isolation of L. monocytogenes from a normally sterile site or, in the setting of miscarriage or stillbirth, isolation of L. monocytogenes from placental or fetal tissue. In cases of pregnancy-associated listeriosis, case may be mother, infant, or both, depending on source(s) of isolation.
§Shiga toxin-producing Escherichia coli
Download the table: Table 4a. Number and Incidence of Infections by Age Group, 2015 Cdc-excel
Pathogen | Age group (yrs) | |||||
---|---|---|---|---|---|---|
<5 | 5-9 | 10-19 | 20-64 | ≥65 | Total | |
Campylobacter | 21.39 | 8.20 | 8.04 | 13.34 | 14.44 | 12.97 |
Listeria§ | 0.30 | 0.00 | 0.00 | 0.14 | 0.96 | 0.24 |
Salmonella | 57.51 | 17.86 | 10.83 | 12.57 | 15.88 | 15.89 |
Shigella | 19.67 | 18.08 | 3.35 | 4.19 | 1.51 | 5.53 |
STEC¶ O157 | 3.72 | 2.39 | 1.41 | 0.53 | 0.49 | 0.95 |
STEC non-O157 | 6.76 | 2.00 | 2.35 | 1.07 | 1.06 | 1.64 |
Vibrio | 0.07 | 0.39 | 0.16 | 0.42 | 0.65 | 0.39 |
Yersinia | 0.74 | 0.16 | 0.21 | 0.20 | 0.57 | 0.29 |
Cryptosporidium | 7.60 | 4.39 | 3.04 | 3.06 | 2.30 | 3.31 |
Cyclospora | 0.00 | 0.00 | 0.02 | 0.17 | 0.17 | 0.13 |
*Per 100,000 population
†Data are preliminary
§Listeria cases defined as isolation of L. monocytogenes from a normally sterile site or, in the setting of miscarriage or stillbirth, isolation of L. monocytogenes from placental or fetal tissue. In cases of pregnancy-associated listeriosis, case may be mother, infant, or both, depending on source(s) of isolation.
¶Shiga toxin-producing Escherichia coli
Download the table: Table 4b. Number and Incidence of Infections by Age Group, 2015 Cdc-excel
Rank | Salmonella serotype | Number of cases | Incidence* |
---|---|---|---|
1 | Enteritidis | 1,358 | 2.79 |
2 | Newport | 816 | 1.68 |
3 | Typhimurium | 739 | 1.52 |
4 | Javiana | 557 | 1.15 |
5 | I 4,[5],12:i:- | 491 | 1.01 |
6 | Poona | 197 | 0.40 |
7 | Muenchen | 181 | 0.37 |
8 | Heidelberg | 153 | 0.31 |
9 | Saintpaul | 148 | 0.30 |
10 | Infantis | 144 | 0.30 |
*Per 100,000 persons
†Among 6,827 Salmonella isolates that were fully serotyped
§Data are preliminary
Download the table: Table 5. Number and Incidence of Salmonella Infections by Serotype, 2015 Cdc-excel
Rank | STEC serogroup | Number of cases | Incidence* |
---|---|---|---|
1 | 26 | 198 | 0.41 |
2 | 103 | 161 | 0.33 |
3 | 111 | 111 | 0.23 |
4 | 121 | 29 | 0.06 |
5 | 145 | 21 | 0.04 |
*Per 100,000 persons
†Among 606 STEC isolates that were fully typed; additional serogroups include 118 (20), 45 (13), 186 (8), 5 (5), 71 (5), 113 (4), 91 (4), 128 (3), 98 (3), 117 (2), 156 (2), 183 (2), 69 (2), 1 (1), 119 (1), 146 (1), 174 (1), 175 (1), 178 (1), 22 (1), 28 (1), 3 (1), 32 (1), 61 (1), 77 (1), 84 (1)
§Data are preliminary
Download the table: Table 6. Number and Incidence of E. coli Infections by Serogroup, 2015 Cdc-excel
Rank | Species | Number of cases | Incidence* |
---|---|---|---|
1 | Vibrio parahaemolyticus | 113 | 0.23 |
2 | Vibrio alginolyticus | 27 | 0.06 |
3 | Vibrio vulnificus | 12 | 0.02 |
4 | Vibrio cholerae | 7 | 0.01 |
5 | Vibrio fluvialis | 7 | 0.01 |
6 | Vibrio hollisae | 6 | 0.01 |
7 | Vibrio mimicus | 3 | 0.01 |
*Per 100,000 persons
†Among 175 isolates that were fully speciated
§Data are preliminary
Download the table: Table 7. Number and Incidence of Vibrio Infections by Species, 2015 Cdc-excel